Risk groups for early bladder cancer
Doctors classify bladder cancer that has not grown into the muscle layer of the
bladder wall into risk groups. These risk groups are based on several factors,
including the size and
Any non-invasive and non-muscle-invasive bladder cancers are classified as low, intermediate or high risk.
Low risk@(headingTag)>
Bladder cancer is low risk when:
- there is only one low-grade tumour that is 3 cm or smaller
- there is no carcinoma in situ (CIS)
Intermediate risk@(headingTag)>
Bladder cancer is intermediate risk when:
- it comes back within 1 year and it is low-grade papillary carcinoma only within the lining of the bladder (non-invasive papillary carcinoma)
- there is only 1 low-grade tumour and it is larger than 3 cm
- there are many low-grade papillary carcinomas within the lining of the bladder
- there is a high-grade tumour that is 3 cm or smaller
- there is a low-grade tumour that has grown into the connective tissue layer of the bladder
High risk@(headingTag)>
Bladder cancer is high risk when:
- there is a high-grade tumour that has grown into the connective tissue layer of the bladder
- it comes back only within the lining of the bladder and it is high-grade papillary carcinoma
- there is a high-grade tumour that is larger than 3 cm or there are many high-grade tumours
- there is carcinoma in situ (CIS)
- there are many tumours that are larger than 3 cm and low-grade papillary carcinomas
-
it is high grade and
immunotherapy with bacillus Calmette-Guérin (BCG) did not work - it is a variant type of urothelial carcinoma
- it has grown into small lymph vessels and blood vessels around the bladder (called lymphovascular invasion, or LVI)
- it is high grade and has grown into the part of the urethra that runs through the prostate (called the prostatic urethra)
Your trusted source for accurate cancer information
With just $5 from readers like you, we can continue to provide the highest quality cancer information for over 100 types of cancer.
We’re here to ensure easy access to accurate cancer information for you and the millions of people who visit this website every year. But we can’t do it alone.
If everyone reading this gave just $5, we could achieve our goal this month to fund reliable cancer information, compassionate support services and the most promising research. Please give today because every contribution counts. Thank you.